C57BL/6NCya-Lars2em1/Cya
Common Name:
Lars2-KO
Product ID:
S-KO-00248
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Lars2-KO
Strain ID
KOCMP-102436-Lars2-B6N-VA
Gene Name
Product ID
S-KO-00248
Gene Alias
Kiaa0028; LEURS
Background
C57BL/6NCya
NCBI ID
Modification
Conventional knockout
Chromosome
9
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Lars2em1/Cya mice (Catalog S-KO-00248) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000038863
NCBI RefSeq
NM_153168
Target Region
Exon 4
Size of Effective Region
~0.1 kb
Detailed Document
Overview of Gene Research
Lars2, leucyl-tRNA synthetase 2, is an enzyme responsible for synthesizing mitochondrial leucyl-tRNA, crucial for maintaining mitochondrial function. It is involved in pathways like the phosphatidylinositol 3-kinase/protein kinase B (PI3K-AKT) pathway. Genetic models, especially knockout models, are valuable for studying its functions in various biological processes and disease conditions [1,4,5].
In a KO mouse model, knockout of lars2 in hippocampal neurons led to cognitive impairment as shown by the Barnes maze test, novel object recognition test, and nest-building experiments. Immunofluorescence assays indicated an increase in p-tau, atrophy in the hippocampal region, and a decrease in neurons, suggesting Lars2 is a potential therapeutic target for Alzheimer's disease [1]. In ovarian granulosa cells, silencing of LARS2 inhibited cell proliferation, promoted apoptosis, induced mitochondrial dysfunction and ROS accumulation, which is related to premature ovarian insufficiency (POI) [3]. In colorectal cancer, deletion of Lars2 gene repressed CRC immunoevasion as leucine-tRNA-synthase-2-expressing B cells contribute to CRC immunoevasion [2].
In conclusion, Lars2 is essential for maintaining mitochondrial function. Its knockout models have revealed its roles in diseases such as Alzheimer's disease, POI, and colorectal cancer. These findings contribute to understanding the underlying mechanisms of these diseases and potentially developing new therapeutic strategies.
References:
1. Qian, Wenqi, Yuan, Lin, Zhuge, Weishan, Ni, Haoqi, Lv, Xinhuang. 2024. Regulating Lars2 in mitochondria: A potential Alzheimer's therapy by inhibiting tau phosphorylation. In Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 21, e00353. doi:10.1016/j.neurot.2024.e00353. https://pubmed.ncbi.nlm.nih.gov/38575503/
2. Wang, Zhiqiang, Lu, Zhou, Lin, Shengli, Liu, Ronghua, Chu, Yiwei. 2022. Leucine-tRNA-synthase-2-expressing B cells contribute to colorectal cancer immunoevasion. In Immunity, 55, 1067-1081.e8. doi:10.1016/j.immuni.2022.04.017. https://pubmed.ncbi.nlm.nih.gov/35659337/
3. Feng, Shujun, Wan, Shan, Liu, Shuangying, Bai, Long, Zhu, Yimin. 2022. LARS2 Regulates Apoptosis via ROS-Mediated Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Ovarian Granulosa Cells. In Oxidative medicine and cellular longevity, 2022, 5501346. doi:10.1155/2022/5501346. https://pubmed.ncbi.nlm.nih.gov/35585880/
4. Li, Dingfeng, Gao, Xinyi, Ma, Xiaolin, Zhang, Juan, Liu, Qiang. 2024. Aging-induced tRNAGlu-derived fragment impairs glutamate biosynthesis by targeting mitochondrial translation-dependent cristae organization. In Cell metabolism, 36, 1059-1075.e9. doi:10.1016/j.cmet.2024.02.011. https://pubmed.ncbi.nlm.nih.gov/38458203/
5. Bai, Jingchao, Yan, Meinan, Xu, Yihan, Niu, Liling, Li, Hui. 2024. YAP enhances mitochondrial OXPHOS in tumor-infiltrating Treg through upregulating Lars2 on stiff matrix. In Journal for immunotherapy of cancer, 12, . doi:10.1136/jitc-2024-010463. https://pubmed.ncbi.nlm.nih.gov/39551603/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen